Global Malignant Glioma API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

Date : 02/17/2017 @ 11:39AM
Source : Business Wire

Global Malignant Glioma API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

Research and Markets has announced the addition of the "Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Malignant Glioma Report is to understand the market and pipeline status of the drugs around the Malignant Glioma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Malignant Glioma Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Malignant Glioma.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Malignant Glioma

7. Phase III Drugs for Malignant Glioma

8. Discontinued Drugs for Malignant Glioma

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/c8kg5k/malignant_glioma

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Related Topics: Brain Cancer Drugs

Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V:us D:20171121 19:19:30